Germany· DE-A57-ed1e00c56a29609f
Synarela
A nafarelin product containing nafarelin acetate, registered in Germany by Pfizer Pharma Gmbh. The same ATC class is registered in 12 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Nafarelin is registered in 12 of 19 countries.
Countries holding a registration under ATC H01CA02 (nafarelin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Nafarelin · ATC H01CA02
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Nafarelin Acetate
- Manufacturer
- Pfizer Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- H01CA02
- ATC class
- Nafarelin
- Defined daily dose
- 0.4 mg, N
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nafarelin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandSynarelaParanova Oy
- SwedenSynarela 200 mikrogram/dos Nässpray, lösningMedartuum AB
- CzechiaSYNARELPfizer, spol. s r.o., Praha
- NorwaySynarelPfizer
- IrelandSynarel 200 micrograms/dose Nasal Spray SolutionPfizer Healthcare Ireland Unlimited Company
- IcelandSynarelaPfizer ApS
- NetherlandsSynarel, neusspray 200 microgram per dosisPfizer B.V.
- CanadaSYNARELPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Czechia · Synarel
- Denmark · Synarela
- Spain · Synarel
- Finland · Synarela
- France · Synarel
- United Kingdom (Northern Ireland) · Synarel
- Ireland · Synarel
- Iceland · Synarela
- Netherlands · Synarel
- Norway · Synarela
- Sweden · Synarela
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb498872-1e4c-4b51-83e7-0eb512a689b6 GET /v1/drugs/eb498872-1e4c-4b51-83e7-0eb512a689b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Nasal Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Nafarelin Acetate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about nafarelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.